Related references
Note: Only part of the references are listed.Galectin-3 is associated with arterial stiffness among hemodialysis patients
Qi Zhang et al.
BIOMARKERS IN MEDICINE (2019)
Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study
Evangelos Oikonomou et al.
CURRENT VASCULAR PHARMACOLOGY (2019)
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Anahita Ghorbani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure A Scientific Statement From the American Heart Association
Sheryl L. Chow et al.
CIRCULATION (2017)
Cardiometabolic Traits and Systolic Mechanics in the Community
Jennifer E. Ho et al.
CIRCULATION-HEART FAILURE (2017)
Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure
Begona Lopez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Sherif F. Nagueh et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2016)
Large Artery Stiffness Assessment Using SphygmoCor Technology
Mark Butlin et al.
PULSE (2016)
Serum PINP, PIIINP, galectin-3, and ST2 as surrogates of myocardial fibrosis and echocardiographic left venticular diastolic filling properties
E. Samuli Lepojarvi et al.
FRONTIERS IN PHYSIOLOGY (2015)
Left ventricular mechanical function: clinical correlates, heritability, and association with parental heart failure
Susan Cheng et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT
Inder S. Anand et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Reproducibility of Speckle-Tracking-Based Strain Measures of Left Ventricular Function in a Community-Based Study
Susan Cheng et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2013)
The fibrosis marker galectin-3 and outcome in the general population
R. A. de Boer et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Jennifer E. Ho et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
Maria Kolatsi-Joannou et al.
PLOS ONE (2011)
Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals
Jennifer E. Ho et al.
AIDS (2010)
Circulating Biomarkers of Collagen Metabolism in Cardiac Diseases
Begona Lopez et al.
CIRCULATION (2010)
Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure
Ravi V. Shah et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
Vladislav V. Glinsky et al.
CARBOHYDRATE RESEARCH (2009)
The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients
Yen-Hung Lin et al.
CLINICA CHIMICA ACTA (2009)
Recognition of galactan components of pectin by galectin-3
A. Patrick Gunning et al.
FASEB JOURNAL (2009)
Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
SH Ahmed et al.
CIRCULATION (2006)
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
NC Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures:: the Framingham heart study
J Sundström et al.
EUROPEAN HEART JOURNAL (2004)
Increased collagen type I synthesis in patients with heart failure of hypertensive origin -: Relation to myocardial fibrosis
R Querejeta et al.
CIRCULATION (2004)
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction
UC Sharma et al.
CIRCULATION (2004)
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study
P Jong et al.
LANCET (2003)
Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study
BW Guess et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2003)
Lifetime risk for developing congestive heart failure - The Framingham Heart Study
DM Lloyd-Jones et al.
CIRCULATION (2002)
TIMP-1 - A marker of left ventricular diastolic dysfunction and fibrosis in hypertension
MM Lindsay et al.
HYPERTENSION (2002)
Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients
J Díez et al.
CIRCULATION (2002)
Share Paper
